Xiang Qian, MD
Pain Management · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Qian’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A113730 · Current
Licensed to practise in California · since 2010 · expires 2028-08-31 · Chekiang Medical University Aka Zhejiang Medical University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$50,988
Medicare paid this office $50,988 for 358 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 83 | $9,835 | $67 |
| Return visit (30+ min) | 80 | $9,774 | $97 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 107 | $7,339 | $69 |
| New patient visit (60+ min) | 29 | $5,158 | $178 |
| Injection of trigger points, 3 or more muscles | 15 | $523 | $35 |
See all 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 83 | $9,835 | $67 |
| Return visit (30+ min) | 80 | $9,774 | $97 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 107 | $7,339 | $69 |
| New patient visit (60+ min) | 29 | $5,158 | $178 |
| Injection of trigger points, 3 or more muscles | 15 | $523 | $35 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $250 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $137 | $10 |
Who their Medicare patients are
358 Original Medicare patients in 2024. Average age 73 · Under 65 13% · 85 and older 13% · Women 63% · Also on Medicaid 22% · Health risk score 1.71. Above the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 70% · Depression 35% · Coronary heart disease 30% · Diabetes 29% · Chronic kidney disease 29% · Atrial fibrillation 23% · Heart failure 20% · Cancer 19% · COPD 15% · Stroke 10% · Dementia 8%.
The office billed $607,776, Medicare allowed $68,466 and paid $50,988; for 638 services of 54 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 358 | 638 | 73 | 1.71 | $607,776 | $50,988 |
| 2023 | 385 | 692 | 72 | 1.74 | $529,030 | $55,045 |
| 2022 | 454 | 833 | 71 | 1.88 | $638,351 | $64,096 |
| 2021 | 468 | 1,061 | 70 | 1.74 | $837,393 | $83,436 |
| 2020 | 610 | 1,337 | 69 | 1.79 | $786,670 | $101,364 |
| 2019 | 516 | 1,090 | 71 | 1.76 | $794,798 | $86,358 |
| 2018 | 589 | 1,269 | 69 | 1.75 | $621,445 | $99,213 |
| 2017 | 519 | 974 | 69 | 1.72 | $523,487 | $84,982 |
| 2016 | 392 | 757 | 69 | 1.62 | $614,261 | $67,229 |
| 2015 | 498 | 961 | 67 | 1.73 | $537,590 | $76,500 |
| 2014 | 417 | 755 | 69 | 1.47 | $549,682 | $82,256 |
| 2013 | 119 | 180 | 70 | 1.54 | $185,397 | $22,988 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 117 | $15,225 | $71 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 130 | $9,736 | $75 |
| Return visit (30+ min) | 55 | $5,558 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,962 | $110 |
| New patient visit (60+ min) | 18 | $2,629 | $146 |
| Return visit (30+ min) | 19 | $1,748 | $83 |
| Long return visit (40+ min) | 12 | $1,569 | $131 |
| Injection of trigger points, 3 or more muscles | 16 | $772 | $37 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 19 | $98 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $66 | $5 |
2022: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 225 | $26,121 | $65 |
| Return visit (30+ min) | 69 | $6,375 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,731 | $93 |
| New patient visit (60+ min) | 21 | $3,112 | $148 |
| Return visit (30+ min) | 19 | $2,019 | $84 |
| Long return visit (40+ min) | 16 | $1,690 | $106 |
| Injection of substance into lower spine canal using imaging guidance | 11 | $920 | $84 |
| Injection of trigger points, 3 or more muscles | 12 | $425 | $35 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 23 | $129 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $66 | $5 |
2021: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 252 | $36,661 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $7,715 | $95 |
| New patient visit (60+ min) | 30 | $5,042 | $168 |
| Return visit (30+ min) | 34 | $3,601 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,503 | $116 |
| Ultrasonic guidance for needle placement | 35 | $1,036 | $28 |
| Injection of trigger points, 3 or more muscles | 15 | $550 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $314 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $264 | $11 |
2020: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 374 | $51,554 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $10,408 | $95 |
| New patient visit (60+ min) | 18 | $2,831 | $157 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,816 | $122 |
| New patient visit (45+ min) | 17 | $2,136 | $126 |
| Long return visit (40+ min) | 16 | $1,826 | $107 |
| Return visit (30+ min) | 25 | $1,795 | $62 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $1,237 | $103 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,177 | $69 |
| Injection of substance into lower spine canal using imaging guidance | 12 | $1,024 | $79 |
| Ultrasonic guidance for needle placement | 19 | $762 | $29 |
| Short return visit (20+ min) | 14 | $660 | $47 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $552 | $50 |
| Injection of trigger points, 3 or more muscles | 12 | $529 | $35 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 32 | $417 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $159 | $11 |
2019: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 229 | $30,190 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $8,380 | $94 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 13 | $3,266 | $251 |
| Return visit (30+ min) | 29 | $2,035 | $68 |
| New patient visit (45+ min) | 13 | $1,516 | $117 |
| Long return visit (40+ min) | 15 | $1,399 | $93 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $1,304 | $93 |
| Return visit (30+ min) | 16 | $1,292 | $68 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 11 | $998 | $71 |
| Ultrasonic guidance for needle placement | 27 | $957 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 58 | $704 | $11 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $683 | $57 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 11 | $425 | $39 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $166 | $11 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 361 | $48,265 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $8,217 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 63 | $7,657 | $118 |
| Return visit (30+ min) | 34 | $2,524 | $66 |
| New patient visit (60+ min) | 15 | $2,238 | $149 |
| New patient visit (45+ min) | 20 | $2,132 | $107 |
| Ultrasonic guidance for needle placement | 14 | $420 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $271 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $265 | $11 |
2017: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 239 | $25,062 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 142 | $17,330 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,581 | $93 |
| New patient visit (60+ min) | 23 | $3,234 | $141 |
| Return visit (30+ min) | 43 | $3,208 | $62 |
| New patient visit (45+ min) | 18 | $1,886 | $105 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $987 | $90 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 33 | $369 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $142 | $9 |
2016: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $9,709 | $63 |
| Return visit (30+ min) | 75 | $6,453 | $68 |
| New patient visit (45+ min) | 47 | $5,144 | $109 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 43 | $3,836 | $89 |
| New patient visit (60+ min) | 19 | $2,828 | $149 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,430 | $121 |
| Long return visit (40+ min) | 23 | $2,280 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,481 | $93 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 28 | $1,051 | $36 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 26 | $1,008 | $36 |
| Ultrasonic guidance for needle placement | 16 | $540 | $30 |
2015: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 138 | $13,816 | $63 |
| Daily hospital management of continuous spinal drug administration | 49 | $6,733 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $5,307 | $93 |
| New patient visit (45+ min) | 49 | $5,240 | $107 |
| Return visit (30+ min) | 55 | $4,421 | $70 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 63 | $2,543 | $37 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,321 | $122 |
| New patient visit (60+ min) | 15 | $2,252 | $150 |
| Short return visit (20+ min) | 30 | $1,358 | $40 |
| Injections of substances into lower or sacral spine | 14 | $1,080 | $77 |
| Ultrasonic guidance for needle placement | 25 | $800 | $30 |
| Insertion of artery tube for blood sampling or infusion through skin | 11 | $492 | $45 |
| Fluoroscopic guidance for spine or back muscle injection | 17 | $466 | $27 |
2014: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $9,150 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $5,094 | $64 |
| Daily hospital management of continuous spinal drug administration | 35 | $4,113 | $57 |
| Return visit (30+ min) | 52 | $3,956 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 34 | $3,035 | $89 |
| New patient visit (60+ min) | 19 | $2,845 | $150 |
| Anesthesia for procedure on gastrointestinal tract using an endoscope | 18 | $2,759 | $153 |
| New patient visit (45+ min) | 18 | $1,853 | $103 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 38 | $1,537 | $38 |
| Long return visit (40+ min) | 13 | $1,185 | $91 |
| Insertion of artery tube for blood sampling or infusion through skin | 21 | $936 | $45 |
| Short return visit (20+ min) | 13 | $592 | $39 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $521 | $35 |
| Ultrasonic guidance for needle placement | 11 | $330 | $30 |
2013: 3 services
| Return visit (30+ min) | 19 | $1,355 | $68 |
| Short return visit (20+ min) | 13 | $658 | $44 |
| Insertion of artery tube for blood sampling or infusion through skin | 11 | $473 | $43 |
Medicaid work
$3,711 in 2024
Medicaid paid $3,711 for 120 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 120 | $3,711 |
| 2024 | 120 | 1 | 17 | $3,711 |
| 2023 | 110 | 2 | 17 | $3,486 |
| 2022 | 189 | 2 | 18 | $4,106 |
| 2021 | 233 | 1 | 17 | $5,304 |
| 2020 | 202 | 2 | 21 | $5,010 |
| 2019 | 103 | 2 | 22 | $2,464 |
| 2018 | 207 | 1 | 16 | $5,036 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 98 | $2,847 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 12 | $639 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 175 | $3,642 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 14 | $465 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 233 | $5,304 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 172 | $3,740 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 30 | $1,269 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 90 | $2,038 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 13 | $426 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 207 | $5,036 |
Drugs they prescribed that Part D paid
$10,277
Pharmacies billed $10,277 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
143 generic and fewer than 11 brand-name prescriptions · $10,277 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxcarbazepine | 28 | $1,871 | $67 |
| Gabapentin | 28 | $453 | $16 |
| Nortriptyline | 16 | $317 | $20 |
| Pregabalin | 11 | $312 | $28 |
Year by year
| 2024 | 150 | 50 | None | None | $10,277 |
| 2023 | 133 | 41 | None | None | $7,353 |
| 2022 | 167 | 46 | None | 0% | $5,716 |
| 2021 | 105 | 37 | None | 0% | $2,951 |
| 2020 | 83 | 38 | 17% (14) | None | $4,098 |
| 2019 | 91 | 39 | None | None | $7,972 |
| 2018 | 172 | 56 | None | 14% | $27,404 |
| 2017 | 219 | 73 | 7% (16) | 11% | $21,173 |
| 2016 | 302 | 101 | 9% (28) | 14% | $17,747 |
| 2015 | 220 | 81 | 11% (24) | 10% | $15,451 |
| 2014 | 104 | 44 | 23% (24) | 27% | $13,056 |
| 2013 | 39 | 21 | 39% (15) | None | $3,148 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Carbamazepine Er | 12 | $1,464 | $122 |
| Oxcarbazepine | 18 | $1,259 | $70 |
| Nortriptyline | 15 | $364 | $24 |
| Gabapentin | 22 | $266 | $12 |
| Duloxetine | 12 | $237 | $20 |
| Meloxicam | 11 | $50 | $5 |
2022: 6 drugs
| Oxcarbazepine | 20 | $1,358 | $68 |
| Gabapentin | 34 | $727 | $21 |
| Lamotrigine | 27 | $581 | $22 |
| Duloxetine | 23 | $558 | $24 |
| Nortriptyline | 15 | $300 | $20 |
| Venlafaxine Hcl Er | 11 | $92 | $8 |
2021: 4 drugs
| Gabapentin | 18 | $438 | $24 |
| Nortriptyline | 20 | $285 | $14 |
| Duloxetine | 12 | $167 | $14 |
| Lamotrigine | 13 | $123 | $9 |
2020: 2 drugs
| Gabapentin | 20 | $741 | $37 |
| Oxcarbazepine | 11 | $376 | $34 |
2019: 2 drugs
| Gabapentin | 22 | $766 | $35 |
| Duloxetine | 15 | $484 | $32 |
2018: 6 drugs
| Lyrica | 15 | $10,301 | $687 |
| Topiramate | 13 | $646 | $50 |
| Gabapentin | 40 | $527 | $13 |
| Nortriptyline | 14 | $505 | $36 |
| Duloxetine | 15 | $404 | $27 |
| Baclofen | 14 | $239 | $17 |
2017: 4 drugs
| Celecoxib | 16 | $1,048 | $66 |
| Topiramate | 17 | $884 | $52 |
| Gabapentin | 51 | $734 | $14 |
| Nortriptyline | 26 | $624 | $24 |
2016: 7 drugs
| Lidocaine | 13 | $2,623 | $202 |
| Gabapentin | 64 | $1,895 | $30 |
| Nortriptyline | 43 | $704 | $16 |
| Oxcarbazepine | 19 | $639 | $34 |
| Celecoxib | 13 | $429 | $33 |
| Topiramate | 19 | $240 | $13 |
| Tizanidine | 13 | $161 | $12 |
2015: 5 drugs
| Duloxetine | 24 | $2,118 | $88 |
| Gabapentin | 77 | $1,790 | $23 |
| Celecoxib | 12 | $1,038 | $86 |
| Topiramate | 21 | $567 | $27 |
| Nortriptyline | 12 | $186 | $16 |
2014: 3 drugs
| Lyrica | 11 | $4,735 | $430 |
| Gabapentin | 20 | $759 | $38 |
| Nortriptyline | 12 | $373 | $31 |
Money from drug and device companies
$14,550 in 2025
| 2025 | 2 | 2 | $14,400 | $14,550 |
| 2024 | 1 | 1 | None | $165 |
| 2023 | 1 | 1 | None | $136 |
| 2022 | 5 | 6 | None | $264 |
| 2021 | 1 | 12 | None | $202 |
| 2019 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
Scientia Vascular
$926,130
Held by this doctor · 2025, 2024 · Stock, Stock Ownership · amount invested $400,000
Published ownership or investment in a drug or device company. This is not proof that care is biased.
A payment is not proof that care is biased.
| Ucb Sa | None | $14,400 | 1 payment
|
| BeiGene USA | Brukinsa | $150 | 1 payment
|
See all 2 published payments
| Ucb Sa | Consulting · 2025-11-28 | None | $14,400 |
| BeiGene USA | Meals · 2025-02-14 | Brukinsa | $150 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $165
| Medtronic | Intellis Adaptivestim | $165 | 1 payment
|
2023: $136
| Nevro | Senza | $136 | 1 payment
|
2022: $264
| Vertos Medical | Mild Device Kit | $132 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $86 | 1 payment
|
| Abbott Laboratories | Proclaim | $28 | 1 payment
|
| Impel Pharmaceuticals | Trudhesa | $12 | 1 payment
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $6 | 2 payments
|
2021: $202
| Abbott Laboratories | Proclaim Ipg | $202 | 12 payments
|
2019: $20
| Nevro | Senza Spinal Cord Stimulation System | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1669634226
- Licence
- CA A113730California A113730: Current · expires 2028-08-31
- Trained
- University of Miami, Lm Miller School of Medicine, 2003
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 207L00000X (207L00000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94305
- NPI first listed
- 2008-06-25
- NPI last updated
- 2024-04-11
- NPI record certified
- 2024-04-11
This is when the NPI record was last certified, not a medical board exam.